Please login to the form below

Not currently logged in
Email:
Password:

Oculeve

This page shows the latest Oculeve news and features for those working in and with pharma, biotech and healthcare.

Allergan stumps up $375m for bolt-on acquisitions

Allergan stumps up $375m for bolt-on acquisitions

Allergan's acquisitive streak shows no signs of abating, with the company adding two migraine drugs from Merck &Co and eye disease specialist Oculeve to its portfolio in the last few ... Meanwhile, the Oculeve deal "adds novel, complementary dry eye

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics